Securities Agreement Sample Contracts

AutoNDA by SimpleDocs
SERIES C COMMON STOCK PURCHASE WARRANT APPLIED DNA SCIENCES, INC.
Securities Agreement • October 31st, 2024 • Applied Dna Sciences Inc • Services-testing laboratories • New York

THIS SERIES C COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [___________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Stockholder Approval Date (as defined below) (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Contract
Securities Agreement • October 21st, 2024 • EON Resources Inc. • Crude petroleum & natural gas

NEITHER THESE SECURITIES NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THESE SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES.

COMMON STOCK PURCHASE WARRANT
Securities Agreement • October 22nd, 2024 • Synbio International, Inc. • Florida

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the funding of the first tranche of that certain secured convertible promissory note dated April 22, 2024, in the original principal amount of up to $555,555.55 issued by the Company (as defined below) to the Lender (as defined below) (the “Note”)), Quick Capital, LLC, a Wyoming limited liability company (the “Lender” and including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time during the Exercise Period, to purchase from Natural Harmony Foods, Inc., a Florida corporation (the “Company”), up to 7,142,858 shares of Common Stock (as defined below) (the “Warrant Shares”) at the Exercise Price. The number of Warrant Shares for which this Warrant may be exercised is subject to adjustment in accordance with the terms hereof. This Warrant is issued by the Comp

PRE-FUNDED ORDINARY SHARE PURCHASE WARRANT Swvl Holdings corp
Securities Agreement • November 18th, 2024 • SWVL Holdings Corp • Services-business services, nec • New York

THIS PRE-FUNDED ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Swvl Holdings Corp, a company duly incorporated and existing under the laws of the British Virgin Islands (the “Company”), up to ______ class A ordinary shares, par value $0.0025 per share (the “Ordinary Shares”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON STOCK PURCHASE WARRANT To Purchase ____ Shares of Common Stock of SPINDLE, INC.
Securities Agreement • May 12th, 2015 • Spindle, Inc. • Services-business services, nec

THIS COMMON STOCK PURCHASE WARRANT CERTIFIES that, for value received, Richard G. Stewart (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the third anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Spindle, Inc., a Nevada corporation (the “Company”), up to _____shares (the “Warrant Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $0.50, subject to adjustment hereunder. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein.

PETRO RIVER OIL CORP. WARRANT
Securities Agreement • February 6th, 2019 • Petro River Oil Corp. • Crude petroleum & natural gas

PETRO RIVER OIL CORP., a Delaware corporation (the “Company”), hereby certifies that, for value received, ___________ or its registered assigns (the “Holder”), is entitled to purchase from the Company up to a total of __________ shares of common stock, $0.00001 par value per share (the “Common Stock”), of the Company (each such share, a “Warrant Share” and all such shares, the “Warrant Shares”) at an exercise price equal to $0.50 per share (as adjusted from time to time as provided in Section 9, the “Exercise Price”), at any time and from time to time from and after the date hereof and through and including the date that is five years from the date of issuance hereof (the “Expiration Date”), and subject to the following terms and conditions. This Warrant (this “Warrant”) is one of a series of similar warrants issued pursuant to that certain Securities Purchase Agreement, dated as of January 31, 2019, by and among the Company and the Purchasers identified therein (the “Purchase Agreemen

COMMON STOCK PURCHASE WARRANT UNUSUAL MACHINES, INC.
Securities Agreement • October 30th, 2024 • Unusual Machines, Inc. • Radio & tv broadcasting & communications equipment

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received,[*] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after April 30, 2025 (the “Exercise Date”) and on or prior to 5:00 p.m. (New York, New York time) on April 30, 2030 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Unusual Machines, Inc., a Nevada corporation (the “Company”), up to [*] shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

FORM OF WARRANT TO PURCHASE COMMON SHARE PURCHASE OF Edesa Biotech, Inc.
Securities Agreement • October 31st, 2024 • Edesa Biotech, Inc. • Pharmaceutical preparations

THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Pardeep Nijhawan Medicine Professional Corporation or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time from the date hereof until 5:00 p.m. (Toronto time) on __________ (the “Termination Date”), but not thereafter, to subscribe for and purchase from Edesa Biotech, Inc., a British Columbia corporation (the “Company”), up to __________ Common Shares under this Warrant (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Contract
Securities Agreement • December 4th, 2015 • Spendsmart Networks, Inc. • Retail-retail stores, nec • New York
Date of Issuance: 11/1/16 5% CONVERTIBLE DEBENTURE DUE 5/4/17
Securities Agreement • November 18th, 2016 • APT Systems Inc • Services-management consulting services

THIS DEBENTURE is a duly authorized and issued 5% Convertible Debenture of APT Systems Inc. having a principal place of business at 505 Montgomery Street 11th Street San Francisco, CA 94111 (“Company"), due 5/4/17 (the "Debenture").

COMMON STOCK PURCHASE WARRANT METASTAT, INC.
Securities Agreement • June 13th, 2014 • MetaStat, Inc. • Semiconductors & related devices

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_____________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from MetaStat, Inc., a Nevada corporation (the “Company”), up to [________] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(c).

FORM OF CLASS A ORDINARY SHARES PURCHASE WARRANT SOS LIMITED
Securities Agreement • June 12th, 2024 • SOS LTD • Finance services

THIS CLASS A ORDINARY SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issuance Date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the date that is the five (5) year anniversary of the Issuance Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from SOS Limited, a Cayman Islands exempted company (the “Company”), up to [ ] Class A Ordinary Shares (as subject to adjustment hereunder, the “Warrant Shares”). This Warrant is part of units (“Units”), each Unit consisting of one Class A ordinary shares, par value $0.005 per share, (the “Ordinary Shares”) and three warrants (the “Warrant”) to purchase one Ordinary Share, issued pursuant to that certain Securities Purchase Agreement (the “Purchase Agreemen

COMMON STOCK PURCHASE WARRANT Issue Date: May 25, 2017 To Purchase 148,617 Shares of Common Stock of VIVEVE MEDICAL, INC.
Securities Agreement • June 1st, 2017 • Viveve Medical, Inc. • Electromedical & electrotherapeutic apparatus

THIS COMMON STOCK PURCHASE WARRANT CERTIFIES that, for value received, CRG Partners III L.P. (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (the “Initial Exercise Date”) and on or prior to the close of business on the earlier of the tenth anniversary of the Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Viveve Medical, Inc., a Delaware corporation (the “Company”), up to an aggregate of 148,617 shares (the “Warrant Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) in accordance with Section 2 or Section 3 herein. The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $9.50, subject to adjustment hereunder. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein.

Page 1 of 1 ------------------------------------------------------------------- ------------- This memorandum is based on information generally available to the public from sources believed to be reliable. No representation is made that it is accurate...
Securities Agreement • October 14th, 2005 • Bear Stearns Commercial Mortgage Securities Inc • Asset-backed securities

-------------------------------------------------------------------------------- This memorandum is based on information generally available to the public from sources believed to be reliable. No representation is made that it is accurate or complete. Certain assumptions may have been made in this analysis which have resulted in any returns detailed herein. No representation is made that any returns indicated will be achieved. Changes to the assumptions may have a material impact on any returns detailed. Past performance is not necessarily indicative of future returns. Price and availability are subject to change without notice. The foregoing has been prepared solely for informational purposes, and is not an offer to buy or sell or a solicitation of an offer to buy or sell any security or instrument or to participate in any particular trading strategy. Morgan Stanley & Co. Incorporated, Morgan Stanley & Co. International Limited, Morgan Stanley Japan Ltd. and/or their affiliates may ha

Contract
Securities Agreement • May 3rd, 2013 • Intercloud Systems, Inc. • Services-business services, nec

NEITHER THESE SECURITIES NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THESE SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES.

ORGINAL ISSUE DISCOUNT CONVERTIBLE DEBENTURE DUE DECEMBER 13, 2007
Securities Agreement • December 14th, 2005 • Pacific Gold Corp • Gold and silver ores

THIS DEBENTURE is one of a series of duly authorized and issued Original Issue Discount Convertible Debentures of Pacific Gold Corp., a Nevada corporation, having a principal place of business at 157 Adelaide Street West, Ste 600, Toronto, Ontario M5H 4E7 (the “Company”), designated as its Original Issue Discount Convertible Debenture, due December 13, 2007 (the “Debentures”).

SULPHCO, INC. WARRANT
Securities Agreement • January 7th, 2008 • Sulphco Inc • Oil & gas field services, nec • New York

SulphCo, Inc., a Nevada corporation (the “Company”), hereby certifies that, for value received, _____________ or his registered assigns (the “Holder”), is entitled to purchase from the Company up to a total of ________1 shares of common stock, $0.001 par value per share (the “Common Stock”), of the Company (each such share, a “Warrant Share” and all such shares, the “Warrant Shares”) at an exercise price equal to $7.00 per share (as adjusted from time to time as provided in Section 9, the “Exercise Price”), at any time and from time to time from and after the date hereof and through and including the third anniversary of the date hereof (the “Expiration Date”), and subject to the following terms and conditions. This Warrant (this “Warrant”) is one of a series of similar warrants issued pursuant to that certain Amendment No. 2 to Securities Purchase Agreements and Warrants, dated as of November 28, 2007, by and among the Company and the Purchasers identified therein (the “Amendment”). A

WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES AKARI THERAPEUTICS, PLC.
Securities Agreement • November 14th, 2024 • Akari Therapeutics PLC • Pharmaceutical preparations

THIS WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (the “Warrant”) certifies that, for value received, [•] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [•], 2024 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [•], 2027 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Akari Therapeutics, Plc., a public company with limited liability incorporated under the laws of England and Wales (the “Company”), up to [•] Ordinary Shares (the “Warrant Shares”) represented by [•] American Depositary Shares (“ ADSs”), as subject to adjustment hereunder (the “Warrant ADSs”). The purchase price of one Warrant ADS shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON STOCK PURCHASE WARRANT To Purchase 750,000 Shares of Common Stock of EXABYTE CORPORATION
Securities Agreement • November 1st, 2005 • Exabyte Corp /De/ • Computer storage devices • Delaware

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) CERTIFIES that, for value received, IMATION CORP. or its transferee (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of original issuance of this Warrant (the “Initial Exercise Date”) and on or prior to the fifth anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Exabyte Corporation, a Delaware corporation (the “Company”), up to 750,000 shares (the “Warrant Shares”) of Common Stock, par value $0.001 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $2.80, subject to adjustment hereunder. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Agreement for Issuance of Stock (the “Issuance Agreement”), dated Octo

AMERICAN TECHNOLOGY CORPORATION WARRANT-B
Securities Agreement • July 19th, 2005 • American Technology Corp /De/ • Household audio & video equipment

American Technology Corporation, a Delaware corporation (the “Company”), hereby certifies that, for value received, [ ] or its registered assigns (the “Holder”), is entitled to purchase from the Company up to a total of [ ]1 shares of common stock, par value $.00001 per share (the “Common Stock”), of the Company (each such share, a “Warrant Share” and all such shares, the “Warrant Shares”) at an exercise price equal to $7.23 per share (as adjusted from time to time as provided in Section 9, the “Exercise Price”), at any time and from time to time from and after the Effective Date and through and including the 6 month anniversary of the Effective Date (the “Expiration Date”), and subject to the following terms and conditions:

WARRANT
Securities Agreement • July 29th, 2005 • Verso Technologies Inc • Services-computer integrated systems design
AutoNDA by SimpleDocs
COMMON STOCK PURCHASE WARRANT To Purchase 2,250,000 Shares of Common Stock of CyberDefender Corporation
Securities Agreement • November 18th, 2008 • Cyberdefender Corp • Services-prepackaged software

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Newview Finance L.L.C. (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on November 10, 20011 (the “Termination Date”) but not thereafter, to subscribe for and purchase from CyberDefender Corporation, a California corporation (the “Company”), 2,250,000 shares (the “Warrant Shares”) of Common Stock, no par value, of the Company (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is executed and delivered pursuant to that certain Consulting Agreement, dated as of the Initial Exercise Date, between the Holder and the Company (the “Consulting Agreement”).

SERIES A/B] COMMON STOCK PURCHASE WARRANT TRIBUTE PHARMACEUTICALS CANADA INC.
Securities Agreement • January 8th, 2016 • Aralez Pharmaceuticals Inc. • Pharmaceutical preparations

THIS [SERIES A/B] COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 6:30 p.m. (New York time) on the year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from TRIBUTE PHARMACEUTICALS CANADA INC., an Ontario corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON SHARE PURCHASE WARRANT LUCY SCIENTIFIC DISCOVERY INC.
Securities Agreement • December 18th, 2023 • Lucy Scientific Discovery, Inc. • Pharmaceutical preparations • Delaware

This COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received in connection with the issuance of the senior secured convertible promissory note of even date in the principal amount of up to $666,666 (the “Note”) by Lucy Scientific Discovery Inc., a British Columbia, Canada (the “Company”), [_____], a Delaware limited partnership (including any permitted and registered assigns, each a “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from the Company 500,000 common shares (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the Issuance Date in connection with that certain securities purchase agreement, of even date hereof, by and between the Company and the

SECURITIES AGREEMENT
Securities Agreement • August 16th, 2021 • Vivid Seats Inc. • Services-miscellaneous amusement & recreation • Delaware

THIS SECURITIES AGREEMENT (this “Agreement”) is made as of November 5, 2018, by and among HOYA TOPCO, LLC, a Delaware limited liability company (the “Company”), and Stanley Chia (“Employee”), an employee of VIVID SEATS, LLC, a Delaware limited liability company (inclusive of any successor, “Employer”). Capitalized terms used but not otherwise defined herein shall have the meanings set forth in Section 7 of this Agreement, or if not defined herein, the meanings in the LLC Agreement.

PREFERRED INVESTMENT OPTION INMED PHARMACEUTICALS INC.
Securities Agreement • October 30th, 2023 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York

THIS PREFERRED INVESTMENT OPTION (the “Preferred Investment Option”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on April 26, 2029 (the “Termination Date”), but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to shares (as subject to adjustment hereunder, the “Preferred Investment Option Shares”) of Common Shares. The purchase price of one share of Common Shares under this Preferred Investment Option shall be equal to the Exercise Price, as defined in Section 2(b).

INTERNATIONAL ISOTOPES INC. CLASS J WARRANT
Securities Agreement • March 31st, 2011 • International Isotopes Inc • Industrial instruments for measurement, display, and control • New York

International Isotopes Inc., a Texas corporation (the “Company”), hereby certifies that, for value received, __________________ or its registered assigns (the “Holder”), is entitled to purchase from the Company up to a total of ______shares of common stock, $0.01 par value per share (the “Common Stock”), of the Company (each such share, a “Warrant Share” and all such shares, the “Warrant Shares”) at an exercise price equal to $0.43 per share (as adjusted from time to time as provided in Section 9, the “Exercise Price”), at any time and from time to time from and after March 25, 2011 and through and including September 25, 2011 (the “Expiration Date”), and subject to the following terms and conditions.

AMERICAN SCIENTIFIC RESOURCES, INCORPORATED COMMON STOCK WARRANT
Securities Agreement • July 6th, 2010 • American Scientific Resources Inc • Surgical & medical instruments & apparatus • New York

This Warrant is being issued by the Company in a private placement pursuant to the Stock Purchase Agreement by and between the Company and the Holder, dated the date hereof as amended and/or supplemented.

COMMON STOCK PURCHASE WARRANT THE GREATER CANNABIS COMPANY, INC.
Securities Agreement • June 20th, 2017 • Greater Cannabis Company, Inc.

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, EMET CAPITAL PARTNERS LLC, 395 Pearsall Avenue, Unit D, Cedarhurst, NY 11516 Fax: (727) 547-7350, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the sixty month anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from THE GREATER CANNABIS COMPANY, INC., a Florida corporation (the “Company”), up to 440,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Contract
Securities Agreement • November 25th, 2011 • Cyberdefender Corp • Services-prepackaged software
EMRISE CORPORATION SECOND AMENDED AND RESTATED WARRANT
Securities Agreement • February 13th, 2009 • Emrise CORP • Instruments for meas & testing of electricity & elec signals

This Second Amended and Restated Warrant (“Warrant”), dated as of February 12, 2009, amends, restates and supersedes that certain Amended and Restated Warrant, dated as of August 20, 2008 (the “First Amended Warrant”), granted to Private Equity Management Group, LLC by EMRISE Corporation, a Delaware corporation (the “Company”). In consideration of the surrender and cancellation of the First Amended Warrant, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company hereby certifies that, pursuant to the terms of the Commitment Letter dated November 7, 2007 by and between the Company and Private Equity Management Group, Inc., Holder is entitled to purchase from the Company up to a total of 387,879 shares of Common Stock (each such share, a “Warrant Share” and all such shares, the “Warrant Shares”), at any time and from time to time from and after the Original Issue Date and through and including November 30, 2014 (the “Expira

WARRANT
Securities Agreement • July 6th, 2006 • Pacific Northwest Productions Inc. • Services-motion picture & video tape production
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!